Requirements for correct storage conditions of Futibatinib

Futibatinib(Futibatinib) is an oral small molecule targeted drug, and its stability is closely related to storage conditions. Reasonable storage methods not only help maintain the efficacy of drugs, but also reduce the risk of medication due to drug deterioration. According to the drug instructions and general drug management principles, special attention should be paid to temperature, light, sealing and other factors during daily storage of forbatinib.

In terms of temperature, it is generally recommended that forbatinib be stored in an environment below 25°C to avoid exposure to high temperatures. Excessively high temperatures may affect the chemical stability of the drug, thereby reducing the activity of the active ingredients. Therefore, it is not recommended to leave medicines near a window exposed to direct sunlight, in a car, or in an environment with large temperature fluctuations for a long time.

Preservation in the dark is also an important principle for the storage of forbatinib. Light, especially strong light, may accelerate the degradation process of some pharmaceutical ingredients. During daily storage, medicines should be placed in their original packaging and stored in a cool, dry, and dark place to avoid frequent exposure to bright environments.

Sealing is also a detail that cannot be ignored. Forbatinib should be kept in its original container and the cap should be tightly closed after taking the medicine to prevent moisture or air from entering. A humid environment may affect the quality of tablets, especially in the south or during the rainy season, so you should pay more attention to moisture-proof measures.

In addition, medicines should be kept away from children and pets to avoid the risk of accidental ingestion. When carrying medicine out and about, it is also recommended to use a light-blocking and moisture-proof medicine box to minimize the time of exposure to unstable environments.

In general, the storage requirements of forbatinib are not complicated, but it requires long-term adherence to standardized operations. Following the principles of "avoiding light, sealing, and storing below 25°C" will help cholangiocarcinoma (CCA) patients use the drug stably and safely throughout the entire treatment cycle, thus ensuring the continuity of treatment effects.

Reference materials:https://www.lytgobi.com/